The Behavioural Pharmacology of Anxiety and Depression
ANNOUNCEMENT OF SPECIAL ISSUES FOR 1998 AND 1999
Animal models of 'anxiety': where next?
Animal models of anxiety; grounds for depression? Commentary on Rodgers, ‘Animal models of anxiety: where next?’
Back to the future. Commentary on Rodgers, ‘Animal models of anxiety: where next?’
Time-dependent sensitization - possible implications for clinical psychopharmacology
Promises and pitfalls. Commentary on Antelman et al., ‘Time-dependent sensitization (TDS) — possible implications for clinical psychopharmacology’
“Curiouser and curiouser”. Commentary on Antelman et al., ‘Time-dependent sensitization (TDS) — possible implications for clinical psychopharmacology’
TDS: Is it a bird, is it a plane … ? Commentary on Antelman et al., ‘Time dependent sensitization (TDS) — possible implications for clinical psychopharmacology‘
The forced swimming test as a model for core and component behavioral effects of antidepressant drugs
Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze
Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety
CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours
Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers
Social influences on morphine conditioned place preference
Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635
Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment
Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress
Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators
Animal models of post traumatic stress disorder
Clinical features of anxiety and depression
Discriminative stimulus and reinforcing effects of the GABAA partial allosteric modulator imidazenll
Brain tryptophan hydroxylase and monoamine oxidase A activities in experimental depression induced by social confrontations (DISC)
Does the behavioural pharmacology of anxiety and depression have a future?
Acute and chronic antidepressants: Effects in conflict models of anxiety in rats
Different pattern of interaction of three anti-anxiety compounds (chlordiazepoxide, diazepam and buspirone) with naloxone
Disinhibitory effects of LY354740, a new mGluR2 agonist, on behaviors suppressed by electric shock, in rats and pigeons
Conditioned behavioral models of anxiety: conflict procedures reconsidered
Sex, drugs, and defensive psychopathology: Female models for (mainly) female disorders
Pharmacological properties of RPR 102681, a novel CCK-B receptor antagonist
Flesinoxan: effects of temperature, heart rate and stress-induced hyperthermia in telemetered mice
Stress, anxiety and depression
Anxiolytic profile of S 16924, a novel antipsychotic possessing marked serotoni (5-HT)1A receptor agonist properties
Can we understand antidepressants without using animal models of depression?
Influence of naloxone on corticosteroid content and state of oxidative system in blood in depressive patients with manifested syndrome of depersonalization
The effect of imipramine on the biosynthesis of dopamine receptors and proenkephalin in a chronic mild stress model of depression
Effect of inositol treatment on the behavior of macaque monkeys
Mirrored chamber as a predictor of clinically anxiety attenuating antidepressants
Depression: clinical considerations for behavioural pharmacologists
The 5-HT1A antagonist WAY100635 does not precipitate withdrawal in rats pretreated with the 5-HT1A agonist S-14506
Comparison of the behavioural profiles of non-selective and BZ-1 (ω1) selective benzodiazepine receptor hypnotics in animal models of anxiety
Animal models of obsessive-compulsive disorder
Loss of chlordiazepoxide anxiolysis in plus-maze-experienced mice depends upon initial exposure to the enclosed (but not open) arms
Oxytocin: a modulator of the endocrine and behavioural responses to stress
The effect of intra-amygdaloid micro-injections of the 5-HT1A receptor agonist flesinoxan on the fear-potentiated startle response
The neuropsychology of anxiety: the role of the amygdala
Molecular biological approaches in the behavioural pharmacology of anxiety and depression
Features of the brain serotonergic system in animals with genetic predisposition for the development of depressive state
Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test
Naloxone partially blocks defeat-induced swim immobility in DBA/2 male mice
Social separation-induced changes in hypothalamic-pituitary-adrenal physiology parallel aspects of hypercortisolism in major depression
Serotonergic mechanisms in models of depression
Learned helplessness: one paradigm or many?
The neural substrates of the adult behavioural effects of repeated early maternal separation (REMS): anaesthetised in-vivo microdialysis indicates altered patterns of basal and evoked release of dopamine and glutamate in the nucleus accumbens
Repeated early maternal separation (REMS) has no effect on the acquisition of a discriminated approach task but impairs the acquisition of a novel operant response for conditioned reinforcement in adult rats: a potential model of depression?
The social drinking/dominance test (S.D.T.): an automated social competition test in rats
8-OH-DPAT differentially influences two measures of anxiety: ultrasonic vocalizations and behaviour in the elevated zero maze, in 18 day old rats
Genetic approaches to anxiety and depression
Psychological perspectives on anxiety and depression
Measurement of time-dependent changes in rodent behaviour induced by antidepressants: modification by the 5-HT1A receptor antagonist, way-100635
Effect of the mGluR2/3 agonist, LY354740 on schedule-controlled behaviour in rats
Interaction between GABA and Serotonergic Neurons in the Control of Anxiety in Rats
Resistance to chronic mild stress in rats neonatally exposed to the SSRI Lu 10-134
Anxiety: clinical considerations for behavioural pharmacologists
Comparison of effect of blockade of 5HT1A and 5HT1B receptors on effect of 5HT1 agonists and antidepressants in the forced swim test in mice
Animal models of panic disorder
Are new strategies needed to detect new antidepressants?
Unconditioned behavioural models of anxiety
Behavior type-dependent predisposition to the development of stress-induced depression: effects of the neuropeptide substance P
Effects of GABA-transporter (GAT) inhibitors on activity and anxiety in rats
New prospects in antidepressant drug development
Parallels between pairbond disruption in gerbils and human depression
Evidence for reduced anxiety in mice following repeated benzodiazepine withdrawal
Fluoxetine prevents behavioural signs of withdrawal from diazepam in the model of anxiety in mice
Chronic mill prenatal stress affects development and behavioral depression in rats
5,7-dihydroxytryptamine lesion of median and dorsal raphe nuclei: effects on behaviour in the elevated plus-maze test
Oral administration of fluvoxamine induces Fos-IR in the male rat brain
Effect of drugs at the CCK-B receptor on ultrasound-induced defence behaviour in the rat
A new Windows-based method to register and analyze rat ultrasonic vocalization
The evaluation of construct validity in animal models of depression
Neuropharmacological and neuroanatomical basis of anxiety